Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 3
2009 4
2010 1
2011 1
2013 2
2014 4
2015 2
2016 2
2017 2
2019 7
2020 7
2021 7
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
[ROS1: rearrangements and analytics].
Siebolts U, Merkelbach-Bruse S. Siebolts U, et al. Pathologie (Heidelb). 2023 Feb;44(1):50-52. doi: 10.1007/s00292-022-01162-5. Epub 2022 Nov 15. Pathologie (Heidelb). 2023. PMID: 36378287 German. No abstract available.
Posttraumatic Ocular Hypotony Through Epithelial Downgrowth.
Heinzelmann J, Schober C, Huth A, Siebolts U, Viestenz A. Heinzelmann J, et al. Among authors: siebolts u. Klin Monbl Augenheilkd. 2022 Feb;239(2):191-195. doi: 10.1055/a-1332-1734. Epub 2021 Feb 4. Klin Monbl Augenheilkd. 2022. PMID: 33540462 English, German.
Immunologic hurdles of therapeutic stem cell transplantation.
Utermöhlen O, Baschuk N, Abdullah Z, Engelmann A, Siebolts U, Wickenhauser C, Stocking C, Krönke M. Utermöhlen O, et al. Among authors: siebolts u. Biol Chem. 2009 Oct;390(10):977-83. doi: 10.1515/BC.2009.114. Biol Chem. 2009. PMID: 19642871 Review.
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.
Glaser M, Rasokat A, Prang D, Nogova L, Wömpner C, Schmitz J, Bitter E, Terjung I, Eisert A, Fischer R, John F, von Levetzow C, Michels S, Riedel R, Ruge L, Scharpenseel H, Siebolts U, Merkelbach-Bruse S, Buettner R, Brägelmann J, Wolf J, Scheffler M. Glaser M, et al. Among authors: siebolts u. Lung Cancer. 2023 Oct;184:107344. doi: 10.1016/j.lungcan.2023.107344. Epub 2023 Aug 12. Lung Cancer. 2023. PMID: 37579577 Free article.
New Safety Aspects in Corneal Donation-Studies on SARS-CoV-2-Positive Corneal Donors.
Wille D, Heinzelmann J, Kehlen A, Lütgehetmann M, Nörz DS, Siebolts U, Mueller A, Karrasch M, Hofmann N, Viestenz A, Börgel M, Kuhn F, Viestenz A. Wille D, et al. Among authors: siebolts u. J Clin Med. 2022 Jun 9;11(12):3312. doi: 10.3390/jcm11123312. J Clin Med. 2022. PMID: 35743381 Free PMC article.
How Much Cochlea Do You Need for Cochlear Implantation?
Plontke SK, Fröhlich L, Wagner L, Kösling S, Götze G, Siebolts U, Liebau A, Rahne T. Plontke SK, et al. Among authors: siebolts u. Otol Neurotol. 2020 Jun;41(5):694-703. doi: 10.1097/MAO.0000000000002614. Otol Neurotol. 2020. PMID: 31985710
Expression profiling on subclasses of primary parotid gland carcinomas.
Meinrath J, Haak A, Igci N, Dalvi P, Arolt C, Meemboor S, Siebolts U, Eischeidt-Scholz H, Wickenhauser C, Grünewald I, Drebber U, Büttner R, Quaas A, Klußmann JP, Odenthal M, Beutner D, Meyer M. Meinrath J, et al. Among authors: siebolts u. Oncotarget. 2020 Nov 10;11(45):4123-4137. doi: 10.18632/oncotarget.27797. eCollection 2020 Nov 10. Oncotarget. 2020. PMID: 33227073 Free PMC article.
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.
Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Pötschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Hüttelmaier S. Haase J, et al. Among authors: siebolts u. Mod Pathol. 2021 Jan;34(1):32-41. doi: 10.1038/s41379-020-0630-0. Epub 2020 Jul 27. Mod Pathol. 2021. PMID: 32719445 Free PMC article.
52 results